Universiti Putra Malaysia Researchers have successfully commercialized the STVac7 intranasal spray vaccine innovation for goats and sheep to prevent diseases that attack the lungs or pneumonia to this group of animals to BIO-Angle VACS Sdn Bhd (BAV).
The sale of the Mannhemia Haemolytica Bacterial Polypeptides and Sequences patent, Gene Sequences and Uses Thereof (MY-176715-A) was signed through a tripartite agreement involving UPM, UPM Innovation Sdn Bhd and BAV witnessed by YBrs. Dr Mohd Zabri Yusoff, Deputy Secretary General (Policy), Ministry of Higher Education recently.
In this regard, the Faculty congratulates and congratulates on the success of Prof. Dr. Mohd Zamri Saad and a group of researchers involved in the commercialization of the vaccine.
Date of Input: 29/09/2021 |
Updated: 29/09/2021 | mjamil